STOCKHOLM -September 1, 2021 - Martin Ingvar, Member of the Board ofContextVision , has onSeptember 1, 2021 purchased 6,000 shares inContextVision AB at an average price ofNOK 24.41 per share. After the transaction, Mr Ingvar holds a total of 6,000 shares inContextVision AB . With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction:Name of listed entity:ContextVision AB ISIN number: SE0014731154 Stock ticker: CONTXName of primary insider:Martin Ingvar Relation to listed entity: Member of the Board of Directors Trade: 6,000 shares Date:01.09.2021 Average purchase price:NOK 24.41 per share Primary insider's total shareholdings post-purchase: 6,000 shares Primary insider's percentage shareholding post-purchase: 0.00008% ### For further information, please contactContextVision's CEO,Fredrik Palm , at Fredrik.palm@contextvision.se or visit www.contextvision.com (http://www.contextvision.com/). ### AboutContextVision ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X- ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.ContextVision is now entering the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care. The company, established in 1983, is based inSweden with local representation in theU.S. ,Japan ,China andKorea .ContextVision is listed on theOslo Stock Exchange under the ticker CONTX. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source